[1]谢雨萌,毛乾国.非酒精性脂肪肝患者中医体质及相关证型研究[J].医学信息,2018,31(07):46.[doi:10.3969/j.issn.1006-1959.2018.07.016]
　XIE Yu-meng,MAO Qian-guo.Study on TCM Constitution and Correlative Syndromes of Nonalcoholic Fatty Liver Patients[J].Journal of Medical Information,2018,31(07):46.[doi:10.3969/j.issn.1006-1959.2018.07.016]
点击复制

非酒精性脂肪肝患者中医体质及相关证型研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年07期
页码:
46
栏目:
综述
出版日期:
2018-04-01

文章信息/Info

Title:
Study on TCM Constitution and Correlative Syndromes of Nonalcoholic Fatty Liver Patients
文章编号:
1006-1959（2018）07-0046-04
作者:
谢雨萌1; 毛乾国2
1.福建中医药大学，福建 福州 350000；2.厦门市中医院肝病中心，福建 厦门 361000
Author(s):
XIE Yu-meng1; MAO Qian-guo2
1.Fujian University of Traditional Chinese Medicine,Fuzhou 350000,Fujian,China; 2.Center for Liver Diseases,Xiamen Traditional Chinese Medicine Hospital,Xiamen 361000,Fujian,China
关键词:
非酒精性脂肪肝; 体质; 中医体质学说; 证型
Keywords:
Key words：Non-alcoholic fatty liver; Constitution; TCM constitution theory; Syndrome type
分类号:
R256.4
DOI:
10.3969/j.issn.1006-1959.2018.07.016
文献标志码:
A
摘要:
近年来，随着本病的发病率逐年上升，对NAFLD患者这一患病群体的中医体质学和中医证型研究也日臻丰富。本文概述NAFLD的中医辨证分型研究和回顾中医体质学说的发展历程，以及归纳整理各医家对NAFLD患者不同体质类型及相关中医证型的研究，通过分析临床研究结果，总结不同体质类型及相关证型的分布规律，旨在为NAFLD的临床预防和治疗提供新思路。
Abstract:
Abstract：In recent years,with the incidence of the disease rising year by year,the study on TCM physique and TCM syndromes of NAFLD patients has become more and more abundant.This paper summarizes the research on TCM syndrome differentiation and classification of NAFLD and reviews the development course of TCM constitution theory,and summarizes and arranges the research of different physique types and related TCM syndromes of NAFLD patients by analyzing the clinical research results.To summarize the distribution of different physique types and related syndromes in order to provide new ideas for clinical prevention and treatment of NAFLD.

参考文献/References:

[1]中华医学会肝病学分会脂肪肝和酒精性肝病学组.中国非酒精性脂肪性肝病诊疗指南[J].中国医学前沿杂志(电子版),2012,4(7):4-10． [2]范建高.脂肪性肝病[M].北京:人民卫生出版社,2013．[3]季光,郑培永.中医药治疗脂肪肝的研究评述[J].中医药学刊,2004,22(1):87-90． [4]中华中医药学会脾胃病分会.非酒精性脂肪性肝病中医诊疗共识意见[J].北京中医药,2011,30（2）：83-86. [5]陈阳,冷雪,杜莹,等.非酒精性脂肪肝中医证候分布特点及与临床指标的相关性分析[J].中华中医药学刊,2014(7):1556-1558. [6]范小芬,邓银泉,吴国琳,等.非酒精性脂肪性肝病中医证型分布及证候特点研究[J].中国中西医结合杂志,201l,3l(10):1332-1336． [7]李少东,李红山,冯琴,等．脂肪肝中医证型分类的文献分析[J].中西医结合肝病杂志,2006,16(4)：255-257． [8]俊丽,郭文海,李海涛,等.中医体质辨识与亚健康调控[J].中医药学报,2013,41(3):12-13． [9]王琦,李英帅,刘铜华．《黄帝内经》的体质养生思想[J].中华中医药杂志,2011,26(10)：2199-2202． [10]王琦,盛增秀.中医体质学说[M].南京:江苏科学技术出版社,1982． [11]王琦.中医体质学[M].北京:中国中医药科技出版社,1999． [12]王琦.9种基本中医体质类型的分类及其诊断表述依据[J].北京中医药大学学报,2005，28(4):1-9． [13]匡调元.中医体质病理学[M].上海:上海科学普及出版社,2000． [14]陈慧珍.妇女体质分型与临床意义[J].广西中医药,1988,11(1):25． [15]中华医学会.中医体质分类与判定[J].世界中西医结合杂志,2009,4(4):303-304． [16]匡调元.论辨证与辨体质[J].中国中医基础医学杂志,2002, 8(2):1-5． [17]何裕民,刘文龙.新编中医基础理论[M].北京：北京医科大学中国协和医科大学联合出版社,1996． [18]王慧英,李红梅,杨蓓,等.141例脂肪肝患者的中医体质类型分布特点及其与证候的关系[J].北京中医药大学学报,2010,33(7):500-502. [19]罗伟,马建伟,董静,等.非酒精性脂肪肝218例中医体质类型与证型分布研究[J].环球中医药,2014(6):453-455. [20]许羽洁．非酒精性脂肪肝病患者中医体质类型与中医证型关系的初步研究[D]．南京中医药大学，2016．

相似文献/References:

[1]刘 瑜,王 星,代 萌,等.2型糖尿病合并非酒精性脂肪肝的危险因素研究[J].医学信息,2018,31(23):108.[doi:10.3969/j.issn.1006-1959.2018.23.029]
　LIU Yu,WANG Xing,DAI Meng,et al.Study on Risk Factors of Type 2 Diabetes Mellitus with Non-alcoholic Fatty liver Disease[J].Journal of Medical Information,2018,31(07):108.[doi:10.3969/j.issn.1006-1959.2018.23.029]
[2]于 淙,欧阳天佐,周 培.吡格列酮治疗非酒精性脂肪肝有效性及安全性的Meta分析[J].医学信息,2020,33(13):60.[doi:10.3969/j.issn.1006-1959.2020.13.017]
　YU Cong,OUYANG Tian-zuo,ZHOU Pei.Meta-analysis of the Efficacy and Safety of Pioglitazone in the Treatment of Non-alcoholic Fatty Liver[J].Journal of Medical Information,2020,33(07):60.[doi:10.3969/j.issn.1006-1959.2020.13.017]
[3]秦 莉,邱秀霞.肝病降脂颗粒对非酒精性脂肪肝患者肝脏生化及血脂水平的影响[J].医学信息,2022,35(21):65.[doi:10.3969/j.issn.1006-1959.2022.21.014]
　QIN Li,QIU Xiu-xia.Effect of Ganbing Jiangzhi Granules on Liver Biochemistry and Blood Lipid Levels in Patients with Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2022,35(07):65.[doi:10.3969/j.issn.1006-1959.2022.21.014]
[4]刘永芳,王 莹.付义主任治疗IgA肾病经验[J].医学信息,2020,33(21):155.[doi:10.3969/j.issn.1006-1959.2020.21.048]
[5]黄丽玲,吴春城,梁惠卿,等.血清标志物壳多糖酶3样蛋白1评价肝纤维化的研究[J].医学信息,2021,34(10):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]
　HUANG Li-ling,WU Chun-cheng,LIANG Hui-qing,et al.Serum Marker Chitinase 3-like Protein 1 in the Evaluation of Liver Fibrosis[J].Journal of Medical Information,2021,34(07):32.[doi:10.3969/j.issn.1006-1959.2021.10.009]
[6]郭月欢,甘惠中.幽门螺旋杆菌感染与非酒精性脂肪肝的相关性研究[J].医学信息,2022,35(08):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
　GUO Yue-huan,GAN Hui-zhong.Correlation Between Helicobacter Pylori Infection and Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2022,35(07):89.[doi:10.3969/j.issn.1006-1959.2022.08.021]
[7]陈 超,陈冯梅.血清尿酸/肌酐比值与老年人非酒精性脂肪肝的相关性研究[J].医学信息,2023,36(19):71.[doi:10.3969/j.issn.1006-1959.2023.19.014]
　CHEN Chao,CHEN Feng-mei.Correlation Between Serum Uric Acid/Creatinine Ratio and Nonalcoholic Fatty Liver Disease in the Elderly[J].Journal of Medical Information,2023,36(07):71.[doi:10.3969/j.issn.1006-1959.2023.19.014]
[8]王 晶,曹名波.非酒精性脂肪肝相关基因多态性的研究进展[J].医学信息,2023,36(24):183.[doi:10.3969/j.issn.1006-1959.2023.24.043]
　WANG Jing,CAO Ming-bo.Research Progress on Gene Polymorphisms Related to Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2023,36(07):183.[doi:10.3969/j.issn.1006-1959.2023.24.043]
[9]洪 军.血脂、血糖及肝功能检测在非酒精性脂肪肝中的诊断作用[J].医学信息,2024,37(14):119.[doi:10.3969/j.issn.1006-1959.2024.14.023]
　HONG Jun.Diagnostic Role of Blood Lipids, Blood Glucose and Liver Function Tests in Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2024,37(07):119.[doi:10.3969/j.issn.1006-1959.2024.14.023]
[10]杜胜兰,贺 茜,曾 俊,等.高尿酸血症与非酒精性脂肪肝相关性研究进展[J].医学信息,2025,38(04):176.[doi:10.3969/j.issn.1006-1959.2025.04.034]
　DU Shenglan,HE Qian,ZENG Jun,et al.Research Progress on the Correlation Between Hyperuricemia and Nonalcoholic Fatty Liver Disease[J].Journal of Medical Information,2025,38(07):176.[doi:10.3969/j.issn.1006-1959.2025.04.034]

更新日期/Last Update: 2018-04-01